De-stress · Brain health technique
Psychedelic-Assisted Therapy (Clinical Trials)
Evidence grade: Experimental
Controlled, therapist-guided sessions using agents such as psilocybin or MDMA to process trauma, anxiety, or existential distress under medical supervision.
- Practice
- De-stress
- Principle
- Restoration
- Tactic
- Clinical Therapy
- Evidence grade
- Experimental
- Strength of evidence
- Low
How to practice Psychedelic-Assisted Therapy (Clinical Trials)
Only pursue within FDA-approved or IRB-regulated clinical trials or licensed programs. Requires screening for psychiatric and cardiovascular contraindications. Sessions include structured preparation, dosing, and integration therapy. Not suitable for unsupervised or recreational use; legal status remains restricted.
The evidence behind Psychedelic-Assisted Therapy (Clinical Trials)
Early phase 2/3 trials show large, sustained reductions in PTSD, depression, and anxiety. Mechanism: enhanced neuroplasticity and emotional reconsolidation via 5-HT2A and oxytocin pathways. However, data remain limited to research settings, with uncertain long-term safety and accessibility. Evidence promising but not yet generalizable.
More De-stress techniques
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.